Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
IONIS PHARMACEUTICALS INC (IONS)
|
|
Balance Sheet |
|
|
|
Standardized | As Reported |
Annual | Quarterly |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 8-K | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
ASSETS | | | | | | | | |
Current assets: | | | | | | | | |
Cash and cash equivalents | 424.8 | 2,347.0 | 276.5 | 315.0 | 521.9 | 542.5 | 869.2 | 633.0 |
Short-term investments | 1,960.6 | | 1,710.4 | 1,666.7 | 1,499.9 | | 1,245.8 | |
Contracts receivable | 28.0 | | 25.5 | 6.6 | 6.8 | 26.1 | 61.9 | 9.1 |
Inventories | 25.5 | | 22.0 | 20.6 | 19.8 | 24.0 | 24.8 | 22.9 |
Other current assets | 177.9 | 182.0 | 168.3 | 143.2 | 142.8 | 150.6 | 143.4 | 136.6 |
Total current assets | 2,616.8 | 2,529.0 | 2,202.7 | 2,152.1 | 2,191.1 | 2,253.1 | 2,345.0 | 2,155.7 |
Property, plant and equipment, net | 91.6 | 85.0 | 74.3 | 180.8 | 177.0 | 177.7 | 178.1 | 180.1 |
Right-of-use assets | 176.7 | | 181.5 | | | | 18.0 | |
Deposits and other assets | 86.0 | 78.0 | 75.3 | 59.4 | 58.9 | 58.9 | 70.6 | 49.0 |
Total assets | 2,971.1 | 2,885.0 | 2,533.9 | 2,422.0 | 2,456.1 | 2,519.1 | 2,611.7 | 2,414.9 |
|
LIABILITIES AND STOCKHOLDERS' EQUITY | | | | | | | | |
Current liabilities: | | | | | | | | |
Accounts payable | 24.0 | | 17.9 | 20.5 | 10.4 | 16.1 | 11.9 | 8.4 |
Accrued compensation | 29.3 | | 49.2 | 30.4 | 25.0 | 16.5 | 38.8 | 32.3 |
Accrued liabilities | 104.7 | | 140.1 | 128.0 | 134.3 | 99.3 | 88.6 | 75.7 |
Income taxes payable | 24.7 | | 6.2 | 0.0 | 0.0 | 0.9 | 0.0 | 0.5 |
Current portion of deferred contract revenue | 96.3 | | 90.6 | 99.5 | 93.4 | 91.4 | 97.7 | 97.9 |
Other current liabilities | 8.9 | 167.0 | 7.5 | | | | 3.5 | |
Total current liabilities | 288.0 | 167.0 | 311.6 | 283.5 | 267.8 | 228.5 | 240.6 | 279.8 |
Long-term deferred contract revenue | 254.4 | | 287.8 | 294.7 | 315.2 | 333.1 | 351.9 | 362.9 |
|
Convertible senior notes, net | | | | | | | | |
Liability related to sale of future royalties, net | 510.2 | | | | | | | |
Long-term lease liabilities | 175.0 | | 178.9 | | | | 19.4 | |
Long-term obligations | 16.4 | | 7.1 | | | | 6.9 | |
Total liabilities | 2,542.8 | 456.0 | 1,961.0 | 1,827.6 | 1,831.4 | 1,809.5 | 1,840.0 | 1,884.4 |
|
Stockholders' equity: | | | | | | | | |
Common stock | 0.1 | | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Additional paid-in capital | 2,118.3 | | 2,059.9 | 2,034.6 | 2,008.8 | 1,983.1 | 1,964.2 | 1,942.3 |
Accumulated other comprehensive loss | -50.9 | | -57.5 | -63.1 | -54.0 | -48.6 | -32.7 | -27.4 |
Accumulated deficit | -1,639.2 | | -1,429.6 | -1,377.2 | -1,330.2 | -1,225.1 | -1,159.9 | -1,384.5 |
Total stockholders' equity | 428.3 | 487.0 | 572.9 | 594.4 | 624.7 | 709.6 | 771.7 | 530.5 |
Total liabilities and stockholders' equity | 2,971.1 | 2,885.0 | 2,533.9 | 2,422.0 | 2,456.1 | 2,519.1 | 2,611.7 | 2,414.9 |
|